Adenosine Patent Expiration

Adenosine is used for improving blood flow in certain areas of the body. It was first introduced by Astellas Pharma Us Inc in its drug Adenocard on Oct 30, 1989. Another drug containing Adenosine is Adenoscan. 16 different companies have introduced drugs containing Adenosine.


Adenosine Patents

Given below is the list of patents protecting Adenosine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Adenoscan US5731296 Selective vasodilation by continuous adenosine infusion Mar 24, 2015

(Expired)

Astellas



Adenosine's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Adenosine Generic API Manufacturers

Several generic applications have been filed for Adenosine. The first generic version for Adenosine was by Hikma Pharmaceuticals Usa Inc and was approved on Jun 16, 2004. And the latest generic version is by Fresenius Kabi Usa Llc and was approved on Apr 16, 2018.

Given below is the list of companies who have filed for Adenosine generic, along with the locations of their manufacturing plants worldwide.